Advertisement

Topics

Echelon Biosciences Incorporated Company Profile

17:09 EST 11th December 2018 | BioPortfolio

Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. The company has since changed its name to Echelon Biosciences Incorporated. The company was organized to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease

Location

675 Arapeen Drive, Suite 302
Salt Lake City
Utah
84108
United States of America

Contact

Phone: 801-588-0455
Fax: 801-588-0497
Email: echelon@echelon-inc.com


News Articles [613 Associated News Articles listed on BioPortfolio]

ECHELON-2, a large peripheral T-cell lymphoma trial

Dr Owen O'Connor speaks to ecancer at ASH 2018 about the ECHELON-2 trial. The ECHELON-2 trail tests brentuximab vedotin and CHP (A CHP) vs CHOP in the frontline treatment of patients with CD30 periph...

Seattle Genetics and Takeda report positive data from ECHELON-2 trial

Seattle Genetics and Takeda have reported positive topline results from the Phase II ECHELON-2 trial investigating adcetris (brentuximab vedotin) as...Read More... The post Seattle Genetics and Takeda...

Lead Investigator Highlights ECHELON-1 Lymphoma Data From North American Subgroup

Radhakrishnan Ramchandren, MD, discusses the treatment landscape in Hodgkin and T-cell lymphoma and the results of the North American subgroup analysis of the ECHELON-1 trial.

$SGEN Add’l Analyses from ECHELON-1 Ph 3 Clinical Trial of ADCETRIS®in Newly Diagnosed Advanced Hodgkin Lymphoma #ASH18 https://www.businesswire.com/news/home/20181202005048/en/Seattle-Genetics-Highlights-Additional-Analyses-ECHELON-1-Phase#.XAQRmwzJdJ

$SGEN Add’l Analyses from ECHELON-1 Ph 3 Clinical Trial of ADCETRIS®in Newly Diagnosed Advanced Hodgkin Lymphoma #ASH18 https://www.businesswire.com/news/home/20181202005048/en/Seattle-Ge...

Seattle Genetics, Takeda: Positive ADCETRIS Data From Phase 3 ECHELON-2 Trial

TOKYO (dpa-AFX) - Seattle Genetics, Inc. (SGEN) and Japan's Takeda Pharmaceutical Company Limited announced late Monday positive data from the ECHELON-2 phase 3 clinical trial for ADCETRIS (Brentu...

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Clinical Trials [14 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Efficiency of the Echelon Foot in Traumatic Trans Tibial Amputees

The aim of this work was to test the Echelon foot efficiency to offer enhanced safety, comfort and function over a wide range of walking surfaces, inclines and stairs, thereby improving th...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

This is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care CHOP in ...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Companies [409 Associated Companies listed on BioPortfolio]

Echelon Biosciences Incorporated

Echelon Biosciences was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, and was incorporated under the laws of the state of Utah as Echelon Research La...

Top Echelon Network, Inc

Top Echelon, Inc. was founded in 1988 and was created to help executive recruiters fill their clients’ needs with qualified candidates. We serve as a resource for top-notch recruiters who want to he...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

More Information about "Echelon Biosciences Incorporated" on BioPortfolio

We have published hundreds of Echelon Biosciences Incorporated news stories on BioPortfolio along with dozens of Echelon Biosciences Incorporated Clinical Trials and PubMed Articles about Echelon Biosciences Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Echelon Biosciences Incorporated Companies in our database. You can also find out about relevant Echelon Biosciences Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record